Disease Course and Outcome of 15 Monocentrically Treated Natalizumab-Associated Progressive Multifocal Leukoencephalopathy Patients

Journal of Neurology, Neurosurgery and Psychiatry- United Kingdom

doi 10.1136/jnnp-2013-304897

Full Text

Abstract

Available in

Categories

Date

April 19, 2013

Authors

Stefanie Dahlhaus

Kerstin Hellwig

Publisher

BMJ

Related search

Brain Magnetic Susceptibility Changes in Patients With Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

American Journal of Neuroradiology

Nuclear Medicine

English

JC Virus Persistence Following Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated With Natalizumab

Annals of Neurology

English

Natalizumab-Associated Progressive Multifocal Leukoencephalopathy in Patients With Multiple Sclerosis: A Mini Review

English

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy

Case Reports in Infectious Diseases

English

Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab

English

Progressive Multifocal Leukoencephalopathy

Journal of Multiple Sclerosis

English

Progressive Multifocal Leukoencephalopathy

English

Co-Occurrence of Two Cases of Progressive Multifocal Leukoencephalopathy in a Natalizumab “Infusion Group”

Multiple Sclerosis

English

Anti-Jc Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Annals of Neurology

English